Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation Fellows 2019

The Evolution in PCI Pharmacology Over the Past 25 Years

Presenter: Deepak L. Bhatt

April 12, 2019

Presentation Fellows 2018

ACS Pharmacology for the Interventionalist

Presenter: Duane S. Pinto, Gregg W. Stone

April 13, 2018

Presentation Fellows 2016

Case 2

Presenter: Ajay Kirtane

April 15, 2016

Presentation Fellows 2016

Case 1: Dilemmas in DAPT and PCI Pharmacology

Presenter: Allen Jeremias

April 15, 2016

Presentation Fellows 2016

Antiplatelet Therapy for the Interventionalist

Presenter: Roxana Mehran

April 15, 2016

Presentation Fellows 2015

Case 2

Presenter: Roxana Mehran, David J. Cohen, Kevin J. Croce

May 15, 2015

Presentation Fellows 2015

Case 1

Presenter: Roxana Mehran, David J. Cohen, Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, Roxana Mehran

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

Presentation Fellows 2015

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation Fellows 2014

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: George Dangas

April 12, 2014

Presentation Fellows 2014

Antithrombin Pharmacology for the Interventionalist

Presenter: Sunil Rao

April 12, 2014

Presentation Fellows 2013

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Presenter: Matthew Price

April 16, 2013

Presentation Fellows 2013

Antiplatelet Therapy for the Interventionalist

Presenter: Matthew Price

April 16, 2013

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Presentation Fellows 2012

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Presenter: Deepak Bhatt

April 22, 2012

Presentation Fellows 2012

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Presenter: Michael Ezekowitz

April 22, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

Presentation Fellows 2012

Bivalirudin in ACS and PCI

Presenter: Gregg Stone

April 22, 2012

Advertisement

The Evolution in PCI Pharmacology Over the Past 25 Years

ACS Pharmacology for the Interventionalist

Case 2

Case 1: Dilemmas in DAPT and PCI Pharmacology

Antiplatelet Therapy for the Interventionalist

Case 2

Case 1

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Antiplatelet Therapy for the Interventionalist

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Antiplatelet Therapy for the Interventionalist

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Oral Antiplatelet Agents in PCI and ACS

Bivalirudin in ACS and PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content